DrugPatentWatch Database Preview
Drugs in Development Information for LIK066
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for LIK066?
LIK066 is an investigational drug.
There have been 12 clinical trials for LIK066.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2015.
The most common disease conditions in clinical trials are Diabetes Mellitus, Diabetes Mellitus, Type 2, and Overweight. The leading clinical trial sponsors are Novartis Pharmaceuticals and [disabled in preview].
There are six US patents protecting this investigational drug and seventy-nine international patents.
Summary for LIK066
| US Patents | 6 |
| International Patents | 79 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2015-11-01) |
| Vendors | 6 |
Recent Clinical Trials for LIK066
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. | Novartis Pharmaceuticals | Phase 2 |
| A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity | Novartis Pharmaceuticals | Phase 2 |
| Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients | Novartis Pharmaceuticals | Phase 2 |
Clinical Trial Summary for LIK066
Top disease conditions for LIK066
Top clinical trial sponsors for LIK066
US Patents for LIK066
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LIK066 | Start Trial | C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof | YOUNGENE THERAPEUTICS CO., LTD (China (Shanghai) Pilot Free Trade Zone, CN) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LIK066
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LIK066 | Australia | 2014317663 | 2033-09-09 | Start Trial |
| LIK066 | Canada | 2923522 | 2033-09-09 | Start Trial |
| LIK066 | China | 105518014 | 2033-09-09 | Start Trial |
| LIK066 | China | 107311992 | 2033-09-09 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
